BioSpace News Archive

Harpoon Therapeutics, Inc (“Harpoon”), a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases, today presented preclinical data supporting the development of a new Protease-activated Tri-specific T cell Activating Construct (“ProTriTAC”) platform.

Today, the Food and Drug Administration (FDA) announced that an emergency use authorization (EUA) has been issued for a rapid, single-use test for the detection of Ebola virus (Zaire ebolavirus).

Technavio analysts forecast the global urinary incontinence therapeutics market to grow at a CAGR of over 3% during the forecast period, according to their latest market research report.

Personalis, a leader in advanced genomics for precision oncology, today announced the launch of its universal cancer immunogenomics platform, ImmunoID NeXT™.

The Centre for Addiction and Mental Health (CAMH) and HBC Foundation, the charitable arm of Hudson’s Bay Company (HBC) are pleased to announce a joint collaboration on a national mental health awareness program for young Canadians

CHI Franciscan hospitals earned top-scoring A and B safety grades according to the fall 2018 Leapfrog Hospital Safety Grades released today by the Leapfrog Group.

Symic Bio, a biopharmaceutical company developing novel extracellular matrix targeting drugs, today announced that they were selected for “The Best of The Liver Meeting 2018" at the AASLD international liver meeting and will be presenting on its liver fibrosis program at the upcoming conference in San Francisco.

GS1 Ireland led an international coalition which successfully employed a sterile field scanner during surgery.

Manufacturing inspections are one of the FDA’s most important tools for ensuring the quality of pharmaceutical products used by American patients

Malin Corporation plc. (ISE:MLC, “Malin”), a company investing in highly innovative life sciences companies, is today hosting a Capital Markets Day for institutional investors and analysts in London.